Phase 3 Asthma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with asthma for at least 6 months.
- People who currently use a reliever (rescue) inhaler, such as salbutamol or a similar medication, with or without regular asthma preventer medication.
- Female participants who are not currently pregnant, not breastfeeding, not trying to become pregnant (for at least 30 days before the screening visit and throughout the trial), or who are not able to become pregnant.
Who may not be able to join:
- People who have had a severe, life-threatening asthma episode in the past, such as one that required a breathing tube, caused a seizure due to low oxygen, caused breathing to stop, or led to a loss of consciousness.
- People who have had a respiratory infection (such as a cold, chest infection, or COVID-19) recently — specifically within the past 2 weeks for general infections, or within the past 6 weeks for COVID-19 — or whose infection symptoms have not fully cleared.
- People who currently smoke or have a significant history of smoking (10 pack years or more). This includes cigarettes, vaping or e-cigarettes, hookahs, water pipes, marijuana, or any oral tobacco products used in the past 6 months. People with a positive cotinine test (a urine test that detects tobacco use) would also not be eligible.
- People who have another lung condition alongside asthma, such as COPD, chronic bronchitis, emphysema, cystic fibrosis, pulmonary fibrosis, bronchiectasis requiring treatment, or a combined asthma-COPD diagnosis.
Additional criteria beyond those listed above also apply — the trial site should be contacted directly for the full list of requirements.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Teva Medical Expert, MD, Teva Branded Pharmaceutical Products R&D LLC
Phone: 1-888-483-8279
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change from Baseline forced expiratory volume in one second (FEV1) area under the effect curve over 4 weeks; Change from Baseline trough FEV1 at week 4
Can't join this trial?
Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.